MAGEA3 and melanoma: Two transcriptomic data sets from patients treated with various types of immunotherapies from the TCGA-SKCM cohort and patients with advanced melanoma treated with MAGE-3 antigen-based immunotherapy were downloaded and analyzed to determine the predictive value of ICI score.